Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3) 3
aged (2) 2
analysis (2) 2
article (2) 2
benzimidazoles - therapeutic use (2) 2
clinical trials (2) 2
disease transmission (2) 2
epidemiology (2) 2
female (2) 2
fluorenes - therapeutic use (2) 2
genotype (2) 2
genotype & phenotype (2) 2
health risks (2) 2
hepacivirus - genetics (2) 2
hepatitis (2) 2
hepatitis c (2) 2
hepatitis c virus (2) 2
hepatitis c, chronic - drug therapy (2) 2
hiv (2) 2
human immunodeficiency virus--hiv (2) 2
humans (2) 2
infectious diseases (2) 2
male (2) 2
middle aged (2) 2
risk factors (2) 2
viral load (2) 2
virology (2) 2
virus-infection (2) 2
abridged index medicus (1) 1
activation (1) 1
adherence (1) 1
aids/hiv (1) 1
antiretroviral treatment (1) 1
antiviral agents (1) 1
antiviral agents - therapeutic use (1) 1
arab countries (1) 1
benzimidazoles - adverse effects (1) 1
bioinformatics (1) 1
biology and life sciences (1) 1
care continuum (1) 1
chronic hcv (1) 1
clinical and epidemiologic research (1) 1
clinical outcomes (1) 1
clusters (1) 1
cohort studies (1) 1
collaboration (1) 1
communities (1) 1
comorbidity (1) 1
computer programs (1) 1
confidence intervals (1) 1
correlation analysis (1) 1
costs (1) 1
data analysis (1) 1
data processing (1) 1
direct-acting antivirals (1) 1
dna sequencing (1) 1
dna, viral - blood (1) 1
dolutegravir (1) 1
drm protein (1) 1
drug combinations (1) 1
drug dosages (1) 1
drug resistance (1) 1
drug therapy (1) 1
drug therapy, combination - methods (1) 1
engagement (1) 1
ethnicity (1) 1
evaluation (1) 1
failure (1) 1
fibrosis (1) 1
fibrotest (1) 1
fluorenes - adverse effects (1) 1
furans - therapeutic use (1) 1
genetic aspects (1) 1
genotype 1 infection (1) 1
health (1) 1
health aspects (1) 1
hispanics (1) 1
hiv infection (1) 1
hiv patients (1) 1
holistic medicine (1) 1
human immunodeficiency virus (1) 1
infections (1) 1
infectious disease (1) 1
inhibitor sofosbuvir plus (1) 1
integrase (1) 1
intention to treat analysis (1) 1
interferon (1) 1
interferon-free therapy (1) 1
internal medicine (1) 1
laboratories (1) 1
liver cirrhosis (1) 1
liver diseases (1) 1
longitudinal studies (1) 1
medical laboratories (1) 1
medicine and health sciences (1) 1
medicine, general & internal (1) 1
methods (1) 1
minority & ethnic groups (1) 1
missed clinic visits (1) 1
morbidity (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study
by Kohli, Anita, MD and Kapoor, Rama, MD and Sims, Zayani, BS and Nelson, Amy, RN and Sidharthan, Sreetha, BS and Lam, Brian, PA and Silk, Rachel, RN and Kotb, Colleen, NP and Gross, Chloe, RN and Teferi, Gebeyehu, MD and Sugarman, Kate, MD and Pang, Phillip S, MD and Osinusi, Anu, MD and Polis, Michael A, MD and Rustgi, Vinod, MD and Masur, Henry, MD and Kottilil, Shyam, Dr
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 9, pp. 1049 - 1054
Summary Background Worldwide, although predominantly in low-income countries in the Middle East and Africa, up to 13% of hepatitis C virus (HCV) infections are... 
Infectious Disease | FIBROSIS | INFECTIOUS DISEASES | VIRUS-INFECTION | RIBAVIRIN | FIBROTEST | EPIDEMIOLOGY | PREDICTION | Sofosbuvir - therapeutic use | Humans | Middle Aged | Fluorenes - therapeutic use | Hepacivirus - genetics | Genotype | Male | Hepatitis C, Chronic - drug therapy | Viral Load | DNA, Viral - blood | Female | Aged | Fluorenes - adverse effects | Sofosbuvir - adverse effects | Benzimidazoles - adverse effects | Drug Combinations | Benzimidazoles - therapeutic use | Clinical trials | Arab countries | Hepatitis C virus | Hepatitis C | Health aspects | Analysis | Hepatitis | Genotype & phenotype | Infectious diseases | Liver diseases | Research & development--R&D | Laboratories | Interferon | Infections | Liver cirrhosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
by Kohli, Anita, MD and Osinusi, Anuoluwapo, MD and Sims, Zayani, BS and Nelson, Amy, RN and Meissner, Eric G, MD and Barrett, Lisa L, MD and Bon, Dimitra, MS and Marti, Miriam M, BS and Silk, Rachel, RN and Kotb, Colleen, NP and Gross, Chloe, RN and Jolley, Tim A, RN and Sidharthan, Sreetha, BS and Petersen, Tess, BS and Townsend, Kerry, BA and Egerson, D'Andrea, RN and Kapoor, Rama, MD and Spurlin, Emily, BA and Sneller, Michael, MD and Proschan, Michael, PhD and Herrmann, Eva, PhD and Kwan, Richard, PAC and Teferi, Gebeyehu, MD and Talwani, Rohit, MD and Diaz, Gabbie, RN and Kleiner, David E, MD and Wood, Brad J, MD and Chavez, Jose, MD and Abbott, Stephen, MD and Symonds, William T, PharmD and Subramanian, G Mani, MD and Pang, Phillip S, MD and McHutchison, John, MD and Polis, Michael A, MD and Fauci, Anthony S, MD and Masur, Henry, MD and Kottilil, Shyam, Dr
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1107 - 1113
Summary Background Direct-acting antiviral drugs have a high cure rate and favourable tolerability for patients with hepatitis C virus (HCV). Shorter courses... 
Internal Medicine | INHIBITOR SOFOSBUVIR PLUS | PROTEASE INHIBITOR | MEDICINE, GENERAL & INTERNAL | INTERFERON-FREE THERAPY | VIRUS-INFECTION | CHRONIC HCV | PEGYLATED INTERFERON | GENOTYPE 1 INFECTION | DIRECT-ACTING ANTIVIRALS | OPEN-LABEL | TREATMENT-NAIVE PATIENTS | Thiophenes - therapeutic use | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Furans - therapeutic use | Viral Load | Drug Therapy, Combination - methods | Uridine Monophosphate - analogs & derivatives | Intention to Treat Analysis | Female | Aged | Quinolines - therapeutic use | Sofosbuvir | Benzimidazoles - therapeutic use | Cohort Studies | Uridine Monophosphate - therapeutic use | Clinical trials | Antiviral agents | Hepatitis C | Drug therapy | Hepatitis C virus | Hepatitis | Genotype & phenotype | Drug dosages | Clinical outcomes | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Virologic response following combined ledipasvir and sofusbuvir administration in patients with HCV genotype 1 and HIV co-infection
by Osinusi, Anu and Townsend, Kerry and Kohli, Anita and Nelson, Amy and Seamon, Cassie and Meissner, MD, Eric G and Bon, Dimitra and Silk, Rachel and Gross, Chloe and Price, Angie and Sajadi, Mohammad and Sidharthan, Sreetha and Sims, Zayani and Herrmann, Eva and Hogan, John and Teferi, Gebeyehu and Talwani, Rohit and Proschan, Michael and Jenkins, Veronica and Kleiner, David E and Wood, Brad J and Subramanian, G. Mani and Pang, Phillip S and McHutchison, John G and Polis, Michael A and Fauci, Anthony S and Masur, Henry and Kottilil, Shyam
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, p. 1232
Comorbidity | Analysis | Genotype | Research | HIV infection | Risk factors | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Retention in HIV Care Among Participants in the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers
by Byrd, Kathy K and Hardnett, Felicia and Clay, Patrick G and Delpino, Ambrose and Hazen, Ron and Shankle, Michael D and Camp, Nasima M and Suzuki, Sumihiro and Weidle, Paul J and Patient-Ctr HIV Care Model Team and Patient-Centered HIV Care Model Team and for the Patient-Centered HIV Care Model Team
AIDS Patient Care and STDs, ISSN 1087-2914, 02/2019, Volume 33, Issue 2, pp. 58 - 66
Poor retention in HIV care is associated with higher morbidity and mortality and greater risk of HIV transmission. The Patient-Centered HIV Care Model (PCHCM)... 
Clinical and Epidemiologic Research | care continuum | HIV | pharmacists | retention | SYSTEM | MISSED CLINIC VISITS | INFECTIOUS DISEASES | ACTIVATION | ADHERENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | COSTS | ENGAGEMENT | HEALTH | OUTCOMES | Holistic medicine | Statistical analysis | Communities | Health risks | Regression analysis | Retention | Minority & ethnic groups | Patients | Morbidity | Confidence intervals | Ethnicity | Disease transmission | Collaboration | Human immunodeficiency virus--HIV | Race | Pharmacists | Hispanics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
by Kohli, Anita and Kapoor, Rama and Sims, Zayani and Nelson, Amy and Sidharthan, Sreetha and Lam, Brian and Silk, Rachel and Kotb, Colleen and Gross, Chloe and Teferi, Gebeyehu and Sugarman, Kate and Pang, Phillip S and Osinusi, Anu and Polis, Michael A and Rustgi, Vinod and Masur, Henry and Kottilil, Shyam
The Lancet. Infectious diseases, ISSN 1473-3099, 9/2015, Volume 15, Issue 9, pp. 1049 - 1054
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study
by Kohli, Anita and Osinusi, Anuoluwapo and Sims, Zayani and Nelson, Amy and Meissner, Eric G and Barrett, Lisa L and Bon, Dimitra and Marti, Miriam M and Silk, Rachel and Kotb, Colleen and Gross, Chloe and Jolley, Tim A and Sidharthan, Sreetha and Petersen, Tess and Townsend, Kerry and Egerson, D’Andrea and Kapoor, Rama and Spurlin, Emily and Sneller, Michael and Proschan, Michael and Herrmann, Eva and Kwan, Richard and Teferi, Gebeyehu and Talwani, Rohit and Diaz, Gabbie and Kleiner, David E and Wood, Brad J and Chavez, Jose and Abbott, Stephen and Symonds, William T and Subramanian, G. Mani and Pang, Phillip S and McHutchison, John and Polis, Michael A and Fauci, Anthony S and Masur, Henry and Kottilil, Shyam
Lancet, ISSN 0140-6736, 3/2015, Volume 385, Issue 9973, pp. 1107 - 1113
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort
by Jair, K and McCann, CD and Reed, H and Castel, AD and Perez-Losada, M and Wilbourn, B and Greenberg, AE and Jordan, JA and Subramanian, T and Binkley, J and Taylor, R and Rayeed, N and Akridge, C and Purinton, S and Naughton, J and D'Angelo, L and Rakhmanina, N and Kharfen, M and Wood, A and Serlin, M and Kumar, P and Parenti, D and Monroe, A and Happ, LP and Jaurretche, M and Lewis, B and Peterson, J and Wilcox, R and Rana, S and Horberg, M and Fernandez, R and Hebou, A and Dieffenbach, C and Masur, H and Bordon, J and Teferi, G and Benator, D and Ruiz, ME and Goldstein, D and Hardy, D and DC Cohort Executive Comm and DC Cohort Executive Committee and the DC Cohort Executive Committee
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0214820
The DC Cohort is an ongoing longitudinal observational study of persons living with HIV. To better understand HIV-1 drug resistance and potential transmission... 
RISK | DOLUTEGRAVIR | ANTIRETROVIRAL TREATMENT | FAILURE | MULTIDISCIPLINARY SCIENCES | Evaluation | Public software | HIV patients | Genetic aspects | Nucleotide sequencing | Drug resistance | Statistics | Methods | DNA sequencing | Pediatrics | RNA-directed DNA polymerase | Pipelines | Epidemiology | Risk factors | Next-generation sequencing | Medical laboratories | Webs | Human immunodeficiency virus--HIV | Clusters | Longitudinal studies | Bioinformatics | Public health | Integrase | Data analysis | Risk groups | Health risks | Data processing | Risk analysis | Computer programs | Organic chemistry | Disease transmission | Correlation analysis | DRM protein | Software | Mutation | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.